Week in Review: Commitment Matters

11.15.13 | By

The biopharmaceutical industry has made significant progress over the years, with innovative new treatments improving outcomes for some of the nation’s most debilitating diseases.

AHA/ACC Guidelines

11.15.13 | By

The newly released American Heart Association (AHA) and American College of Cardiology (ACC) Guidelines on the Treatment of Blood Cholesterol and Lifestyle Management to Reduce Atherosclerotic Cardiovascular Risk in Adults have received a great deal of attention over the last couple days and are certain to stimulate further discussion as physicians and patients alike integrate the new rec

Rx Response

11.15.13 | By

Guest Post from Erin Mullen, PhRMA Associate VP and Director of Rx Response

Blog by Dr. Bill Chin

11.14.13 | By

The healthcare community is at an important juncture; we must work together to ensure that policies and regulations align to help us meet the unique challenges and full potential of personalized medicine. Science and technology drive what we can achieve, but they also evolve over time.

A Hero of Medicine

11.14.13 | By

In science – and especially medicine -- there are celebrated men and women whose life work has changed the world.  Doctors Salk and Sabine and their polio vaccines come quickly to mind.  Because of their work, people around the world need never fear the scourge of polio. But among the all-stars of medicine are many great scientists and researchers who, while less well known to the general public, also make a huge contribution to treating patients and preventing disease, as well as transforming our approach to innovative new treatments.

Providing Quality Care

11.13.13 | By

With nearly 1,700 care locations throughout the country and serving more than eight million Veterans, service members and military families each year, the Veterans Health Administration, part of the U.S. Department of Veterans Affairs (VA), is the largest integrated health care system in the country.

Pharmaceutical Clinical Trials in Massachusetts

11.13.13 | By

The report, "Research in Your Backyard:  Pharmaceutical Clinical Trials in Massachusetts," shows widespread clinical research underway throughout the state, including Worcester where we released the report yesterday with the

Discussing Specific Issues Facing the Alzheimer's Community

11.12.13 | By

Over the last few weeks we have devoted a fair bit of time and energy on Alzheimer’s disease. Why? It is one of the most complex diseases we face, it currently afflicts more than 5 million people in the U.S. and its current trajectory is worrisome to say the least.

Dr. William Chin Remarks at 9th Annual Personalized Medicine Conference

“PhRMA’s Outlook on Personalized Medicines”
Dr. William W. Chin, M.D.
Executive Vice President, Science & Regulatory Affairs
The Pharmaceutical Research Manufacturers of America
9th Annual Personalized Medicine Conference
Harvard University
Cambridge, MA
Wednesday, 6 November 2013

Improving Patients' Lives

11.08.13 | By

The phrase “strength in numbers” often rings true for the biopharmaceutical industry. This week we were reminded that when it comes to furthering innovation, collaboration is essential to creating a path forward and finding ways to improve patients’ lives.


Subscribe to RSS - Opinion